CHRYSOS CORP. LIMITED (C79)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

C79

C79 - CHRYSOS CORP. LIMITED

FNArena Sector : Mining Sector Contracting
Year End: June
GICS Industry Group : Commercial & Professional Services
Debt/EBITDA: -1.06
Index: ALL-ORDS

0

LAST PRICE CHANGE +/- CHANGE % VOLUME

$7.37

21 Aug
2026

-0.070

OPEN

$7.44

-0.94%

HIGH

$7.54

290,393

LOW

$7.29

TARGET
$8.70 18.0% upside
OTHER COMPANIES IN THE SAME SECTOR
ALQ . ANG . ARI . CDA . DNL . DOW . EHL . GNG . IMD . IPG . LBL . LYL . MAD . MAH . MIN . MLG . MND . MSV . MYE . NWH . ORI . PRN . RAN . RCR . SGH . SRG . SXE . TEA . VBC . XRF .
FNARENA'S MARKET CONSENSUS FORECASTS
C79: 1
Title FY25
Actual
FY26
Actual
FY27
Forecast
FY28
Forecast
EPS (cps) xxx 1.5 10.0 xxx
DPS (cps) xxx 0.0 0.0 xxx
EPS Growth xxx N/A 100.0% xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 73.2 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx1.5
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx0.1 M
Book Value Per Share xxxxxxxxxxxxxxx169.7
Net Operating Cash Flow xxxxxxxxxxxxxxx13.5 M
Net Profit Margin xxxxxxxxxxxxxxx1,612.61 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx0.90 %
Return on Invested Capital xxxxxxxxxxxxxxx0.75 %
Return on Assets xxxxxxxxxxxxxxx0.63 %
Return on Equity xxxxxxxxxxxxxxx0.90 %
Return on Total Capital xxxxxxxxxxxxxxx-34.07 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-25.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx63 M
Total Debt xxxxxxxxxxxxxxx64 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx26 M
Price To Book Value xxxxxxxxxxxxxxx3.42

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx41.0 M
Capex % of Sales xxxxxxxxxxxxxxx36,946.85 %
Cost of Goods Sold xxxxxxxxxxxxxxx70 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx12 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

12/08/2026

1

Buy

$8.70

18.05%

Chrysos delivered a FY26 result that revealed underlying EBITDA of $27.2m, slightly below Bell Potter's estimates yet up 69%. A significant uplift in AAC stemmed from higher Photon Assay fleet utilisation as increased global exploration activity meant more samples were processed.

The company has guided to FY27 revenue in the range of $108m–$118m and EBITDA in the range of $35m–$42m. A doubling of the fleet to 92 units is expected over the next three years.

Bell Potter upgrades EPS forecasts by 85% for FY27 and 40% for FY28, largely because of material reduction in depreciation following the extension of deployed units' useful life being applied prospectively. Buy rating. Target rises to $8.70 from $7.80.

FORECAST
Bell Potter forecasts a full year FY27 dividend of 0.00 cents and EPS of 10.00 cents.
Bell Potter forecasts a full year FY28 dividend of 0.00 cents and EPS of 14.60 cents.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Shaw and Partners

13/08/2026

1

Buy

$9.00

22.12%

Shaw and Partners maintains a Buy rating for Chrysos with its target price increased to $9.00 from $8.80 following the release of full-year financial results.

Full-year revenue reached $88.1m alongside EBITDA of $27.2m, supported by seven new PhotonAssay deployments bringing the total active unit fleet to 46.

The analyst notes management provided three-year deployment targets pointing to a near doubling of the installed base, providing strong evidence the technology is reaching a commercial inflection point.

For FY27, revenue guidance was set between $108m and $118m, with the broker's estimates factoring in strong operating leverage as corporate overhead growth lags fleet expansion.

The price target movement reflects improved revenue visibility across the expanding contracted pipeline and scaling deployment cadence.

FORECAST
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of 4.10 cents.
Shaw and Partners forecasts a full year FY28 dividend of 0.00 cents and EPS of 3.90 cents.

C79 STOCK CHART